Advertisement

Index by author

January 01, 1999; Volume 288,Issue 1

  1. Adem, Abdu

    1. Selectivity Profile of Muscarinic Toxin 3 in Functional Assays of Cloned and Native Receptors
      Maria C. Olianas, Angela Ingianni, Carlo Maullu, Abdu Adem, Evert Karlsson and Pierluigi Onali
      Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 164-170;

  2. Ahmad, Bashir

    1. Long-Term Sequential Determination of Behavioral Ontogeny of 5-HT1A and 5-HT2 Receptor Functions in the Rat
      Nissar A. Darmani and Bashir Ahmad
      Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 247-253;

  3. Aishita, Hideki

    1. ONO-1603, a Potential Antidementia Drug, Delays Age-Induced Apoptosis and Suppresses Overexpression of Glyceraldehyde-3-Phosphate Dehydrogenase in Cultured Central Nervous System Neurons
      Nobuo Katsube, Katsuyoshi Sunaga, Hideki Aishita, De-Maw Chuang and Ryoichi Ishitani
      Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 6-13;

  4. Al-ani, Bahjat

    1. Evaluation of Proteinase-Activated Receptor-1 (PAR1) Agonists and Antagonists Using a Cultured Cell Receptor Desensitization Assay: Activation of PAR2 by PAR1-Targeted Ligands
      Atsufumi Kawabata, Mahmoud Saifeddine, Bahjat Al-Ani, Lorraine Leblond and Morley D. Hollenberg
      Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 358-370;

  5. Allen, Andrew C.

    1. Novel 3α-Diphenylmethoxytropane Analogs: Selective Dopamine Uptake Inhibitors with Behavioral Effects Distinct from Those of Cocaine
      Jonathan L. Katz, Sari Izenwasser, Richard H. Kline, Andrew C. Allen and Amy Hauck Newman
      Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 302-315;

  6. Andersson, Tommy B.

    1. Characterization of Binding Properties to Human P-Glycoprotein: Development of a [3H]Verapamil Radioligand-Binding Assay
      Stephan Döppenschmitt, Peter Langguth, Carl Gunnar Regårdh, Tommy B. Andersson, Constanze Hilgendorf and Hildegard Spahn-Langguth
      Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 348-357;

  7. Ansari, M. Sib

    1. Characterization of (S)-Des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a Selective High-Affinity Radioligand for 5-Hydroxytryptamine3 Receptors
      William A. Hewlett, Bakula L. Trivedi, Zhang-Jin Zhang, Tomas de Paulis, Dennis E. Schmidt, David M. Lovinger, M. Sib Ansari and Michael H. Ebert
      Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 221-231;

  8. Avram, Michael J.

    1. Uptake of Fentanyl in Pulmonary Endothelium
      Christopher M. Waters, Michael J. Avram, Tom C. Krejcie and Thomas K. Henthorn
      Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 157-163;

  9. Balestra, Mike

    1. [S]-AR-R 15896AR—A Novel Anticonvulsant: Acute Safety, Pharmacokinetic and Pharmacodynamic Properties
      Gene C. Palmer, Robert J. Murray, Carrie L. Cramer, Mary L. Stagnitto, Marilyn K. Knowles, Lou R. Freedman, Mark S. Eismann, Nik Mahmood, Mike Balestra, Alfonso R. Borrelli, Thomas J. Hudzik and Dennis J. McCarthy
      Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 121-132;

  10. Banks, Steven M.

    1. Increasing Doses of Pentoxifylline as a Continuous Infusion in Canine Septic Shock
      Zenaide M. N. Quezado, William D. Hoffman, Steven M. Banks, Robert L. Danner, Peter Q. Eichacker, Gregory M. Susla and Charles Natanson
      Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 107-113;
« Previous (Pages : 1 2 3 4 5 6 ... 25) Next »
Back to top

In this issue

Advertisement